네오팜

092730KOSDAQ

60.0 / 100

Reference Date: 2026-10-23

Financial Score26.5 / 40

News Sentiment12.5 / 25

Momentum11.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Slightly up 1.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Neoparm operates various cosmetics brands, including its flagship 'Atopear', and achieved sales of 132.1 billion KRW and net profit of 27.9 billion KRW in 2025. The company leverages its proprietary MLE formulation technology, which enhances skin barrier function, securing market competitiveness. 'Atopear' has maintained the top position in the sensitive skincare category for 19 consecutive years according to the K-BPI survey.

Number of Employees

192people

Average Salary

63.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

13.07Industry Average 15.005.0Point

In line with industry avg

PBR

1.91Industry Average 1.201.0Point

1.6x industry avg (risky)

ROE

14.95Industry Average 8.005.5Point

1.9x industry avg (good)

Debt Ratio

0.73Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20257.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲16.8% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲7.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 14.7% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position6.0Point

52w upper range (77%)

Current 23,250Won52-week high 25,45052-week low 15,760

1-month return3.0Point

1m 1.09% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0